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Abstract
Background
Rotavirus is the leading cause of acute gastroenteritis in children and is associated with neu-
rological complications such as seizures and encephalopathy. The aim of this study was to
investigate the presentation and complications of rotavirus compared to non-rotavirus gas-
troenteritis in UK children.
Methods
This was a retrospective, case-control, hospital-based study conducted at three sites in east
London, UK. Cases were children aged 1 month to 16 years diagnosed with acute gastroen-
teritis between 1 June 2011 and 31 December 2013, in whom stool virology investigations
confirmed presence of rotavirus by PCR. They were matched by age, gender and month of
presentation to controls with rotavirus-negative gastroenteritis.
Results
Data were collected from 116 children (50 cases and 66 controls). Children with rotavirus
gastroenteritis tended to present more frequently with metabolic acidosis (pH 7.30 vs 7.37,
P = 0.011) and fever (74% versus 46%; P = 0.005) and were more likely to require hospitali-
sation compared to children with non-rotavirus gastroenteritis (93% versus 73%; P = 0.019).
Neurological complications were the most common extra-intestinal manifestations, but did
not differ significantly between children with rotavirus-positive gastroenteritis (RPG) and
rotavirus-negative gastroenteritis (RNG) (24% versus 15%, respectively; P = 0.24). Enceph-
alopathy occurred only in children with rotavirus infection (n = 3, 6%).
Conclusion
Rotavirus causes longer and more severe disease compared to other viral pathogens. Sei-
zures and milder neurological signs were surprisingly common and associated with multiple
pathogens, but encephalopathy occurred only in children with rotavirus gastroenteritis.
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Rotavirus vaccination may reduce seizures and presentation to hospital, but vaccines
against other pathogens causing gastroenteritis are required.
Introduction
Rotavirus is the most common cause of severe gastroenteritis in children under the age of 5
years worldwide [1]. The cumulative annual burden of rotavirus-associated gastroenteritis
globally is about 25 million outpatient visits, 2 million hospital admissions, and 180,000–
450,000 deaths in children<5 years of age [2]. In the European Union, it is estimated that rota-
virus causes each year around 3.6 million episodes of gastroenteritis, 700,000 clinic visits,
87,000 hospitalizations and 231 deaths in children <5 years of age [3]. Most infections are
community-acquired, but rotavirus is also a major cause of nosocomial diarrhoea especially in
infants <6 months of age [4]. There is accumulating evidence that rotavirus infection is not
limited to the intestine [5]. Neurologic manifestations, including afebrile or febrile convul-
sions, meningoencephalitis, encephalopathy and cerebellitis appear to be the most common
extra-intestinal complications [6].
Two oral, live attenuated rotavirus vaccines, a pentavalent bovine-human reassortment vac-
cine (RotaTeq [RV5], Merck and Company, Whitehouse Station, NJ) and a monovalent
human vaccine (Rotarix [RV1], GlaxoSmithKline Biologicals, Rixensart, Belgium), have been
available since 2006 and are recommended by the World Health Organization for routine
immunisation of all infants [7]. The oral monovalent vaccine [RV1] was introduced to the
national immunisation programme in England and Wales on 1 July 2013, as a 2-dose schedule
for infants at 2 and 3 months of age. A systematic review of studies from eight countries
reported a 49–89% reduction in hospital admissions due to rotavirus infection and 17–55%
decrease in hospitalisation rates for gastroenteritis of any cause in children <5 years within
two years after vaccine was introduced [8]. A recent vaccine efficacy study from the UK
reported a 77% reduction in laboratory-confirmed rotavirus infections and a 26% reduction in
all-cause acute gastroenteritis–associated hospitalizations in infants <1 year of age [9].
Although the burden of rotavirus gastroenteritis is well recognised, little information is
available concerning rotavirus-associated complications in the UK. The aim of the present
study was to investigate presentation and complications of rotavirus compared to non-rotavi-
rus gastroenteritis in UK children.
Methods
Study design
This was a retrospective, matched case-control, hospital-based study conducted at three sites
in east London, UK: The Royal London Hospital, Newham University Hospital, and Whipps
Cross University Hospital.
Cases and controls were identified from the computerized virology laboratory database, by
listing all children (age 1 month to 16 years) undergoing stool PCR testing between 1 June
2011 and 31 December 2013. The start date was when multiplex PCR was introduced for
detection of gastroenteritis viruses at our sites; the end date was six months after rotavirus
vaccination was introduced in the national UK schedule. Two triplex PCR were used in the
diagnostic test, one targeting rotavirus and norovirus genotype 1 and 2; and one targeting ade-
novirus 40/41, sapovirus and astrovirus [10]. Cases were children diagnosed with acute gastro-
enteritis in whom rotavirus was detected by PCR; controls were children diagnosed with acute
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gastroenteritis in whom rotavirus was not detected by PCR. Acute gastroenteritis was defined
following review of case notes as an episode of3 loose stools or forceful vomiting occurring
within a 24-hour period in the absence of a previously diagnosed chronic gastrointestinal dis-
ease that could imitate acute gastroenteritis [11]. No formal sample size calculation was per-
formed before data collection. Controls were matched to cases by age, gender and month of
presentation (in respective order of priority). Age of presentation was matched within a range
of 3 months for patients <1 year of age, 6 months for patients between 1 and 2 years old and
12 months for patients >2 years old. Month of presentation was matched within a range of 3
months before or after the month of presentation. Infants<30 days old and children who had
received any doses of rotavirus vaccine were excluded.
Data collection
Anonymised data were extracted from patients’ medical notes and the computerised data sys-
tem by a single investigator and entered into a database. Clinical features and complications
were defined as follows
• Reporting of dehydration was based on the documentation of the clinician in the notes or
the electronic data system. If there was no clinical impression documented, a retrospective
review performed by the investigator based on the clinical criteria outlined in NICE guide-
lines [12]. The same tool was used for children >5 years of age.
• Seizures were classified based on the International League Against Epilepsy (ILAE) scheme
[13].
• Encephalopathy was defined as depressed or altered level of consciousness, lethargy, or per-
sonality change lasting >24 hours based on the criteria of Brighton Collaboration Encepha-
lomyelitis/ADEM Working Group [14].
• Recording of reduced consciousness level was based on the documentation of the clinician
in the notes or the electronic data system. If there was no AVPU or Glasgow Coma Scale
(GCS) assessment documented, a retrospective review performed by the investigator and the
recording was based on the clinical criteria of the Brighton Collaboration Encephalomyeli-
tis/ADEM Working Group for decreased or absent response to environment, defined as
“decreased or absent response to loud noise or painful stimuli, and/or decreased or absent
eye contact, and/or inconsistent or absent response to external stimuli and/or decreased
arousability and/or seizure associated with loss of consciousness” [14].
Statistical analysis
Statistical analysis was done with GraphPad Prism 7. Differences between groups were ana-
lysed using Fisher’s exact test (two-tailed) for categorical variables and the Student t-test or
Mann-Whitney test for continuous variables, after checking for normality of distribution
using the D’Agostino-Pearson and Shapiro-Wilks tests.
Ethics approval and consent to participate
The clinical study was approved by the Joint Research Management Office of Barts Health
NHS Trust, London, UK (Reference number 010202). The study was conducted in accordance
with the Research Governance Framework for Health and Social Care (2005), the World Medi-
cal Association Declaration of Helsinki (1996), the Data Protection Act (1998) and the current
applicable regulatory requirements. Because this was a retrospective review of clinical records,
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written informed consent from caregivers was not obtained. Research studies such as ours that
utilise previously collected (in the course of normal clinical care), non-identifiable data do not
require review by or approval of an NHS Research Ethics Committee, or a formal University
REC.
Results
Of the 153 children with positive stool rotavirus PCR identified through the laboratory infor-
mation system, the records of 136 (89%) were available for review; 86 were subsequently
excluded because they were investigated and treated in a primary care setting without having
to attend the hospital emergency department and therefore no clinical information was avail-
able. 157 control subjects were matched to cases by age, gender and month of presentation.
145 sets of notes (92%) were available for review. 79 cases were subsequently excluded for the
same reasons as above. The final analysis therefore comprised 116 patients: 50 children with
rotavirus-positive gastroenteritis (RPG), and 66 children with rotavirus-negative gastroenteri-
tis (RNG); the final ratio of case:control matching was 1:1.3.
In the RNG group, norovirus was the most common pathogen (n = 16, 24%), followed by
adenovirus (n = 8, 12%), sapovirus (n = 3, 4.5%), astrovirus (n = 3, 4.5%), Salmonella spp.
(n = 1, 1.5%), Campylobacter spp. (n = 1, 1.5%) and Escherichia coli (n = 1, 1.5%); no pathogen
was identified in 28 cases (42%); five children (7.5%) were infected with two or more viruses
(Fig 1). In the RPG group, six children (12%) had a co-infection with another infectious agent
(Fig 2).
Baseline characteristics and clinical presentation
Baseline characteristics and clinical presentation are shown in Tables 1 and 2, respectively.
Children with community-acquired RPG were more likely to be hospitalized than children
with community-acquired RNG (93% versus 73%, respectively; P = 0.019). A higher
Fig 1. Diarrhoea pathogens identified in the stool sample (RNG group).
https://doi.org/10.1371/journal.pone.0194009.g001
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proportion of children with RPG compared to RNG had fever recorded by health care profes-
sionals or reported by parents (74% versus 46%; P = 0.005), and children with RPG tended to
be more likely to have dehydration (44% versus 26%; P = 0.07) and to get readmitted (6% ver-
sus 0%; P = 0.07).
Laboratory variables
Laboratory variables are shown in Table 3.
Fig 2. Diarrhoea pathogens identified in the stool sample in addition to rotavirus / Concomitant or secondary GI infection (RPG
group).
https://doi.org/10.1371/journal.pone.0194009.g002
Table 1. Demographics of children with rotavirus-positive and rotavirus-negative gastroenteritis.
Variable Rotavirus Positive Gastroenteritis
N = 50
Rotavirus Negative Gastroenteritis
N = 66
P value
Age at admission, months; mean (SD) 24 (21) 25 (29) [matching variable]
Female Sex; n (%) 22 (44%) 33 (50%) [matching variable]
Community acquired a; n (%) 41 (82%) 60 (91%) 0.17
Underlying chronic medical condition; n (%) 15 (30%)b 23 (35%)c 0.69
Hospitalized d; n (%)
(excluding those with hospital-acquired disease)
38 (93%)
[n = 41]
44 (73%)
[n = 60]
0.019
SD: Standard Deviation
n shown in square brackets where incomplete data
ª Hospital acquired infection was defined as symptoms that developed 48 hours or more after admission
bPre-existing conditions for rotavirus-positive gastroenteritis: Cardiac (n = 4), Respiratory (n = 6), Gastrointestinal (n = 8), Neurological (n = 5), Haematological
(n = 1), Immunodeficiency (n = 1), Renal (n = 1), Chromosomal disorder (n = 3).
c Pre-existing conditions for rotavirus-negative gastroenteritis: Cardiac (n = 1), Respiratory (n = 1), Gastrointestinal (n = 10), Neurological (n = 2), Haematological
(n = 3), Immunodeficiency (n = 1), Oncology (n = 3), Malnutrition (n = 3), Chromosomal disorder (n = 1).
d Excluding those with hospital-acquired infection.
https://doi.org/10.1371/journal.pone.0194009.t001
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Table 2. Presentation and management of children with rotavirus-positive and rotavirus-negative gastroenteritis.
Variable Rotavirus Positive Gastroenteritis
N = 50
Rotavirus Negative Gastroenteritis
N = 66
P value
Diarrhoea; n (%) 43 (86%) 62 (95%) 0.20
Vomiting; n (%) 37 (74%) 39 (60%) 0.12
Fever; n (%) 37 (74%) 30 (46%) 0.005
Fever, oC (highest); mean (SD) 38.4 (1.0)
[n = 46]
37.8 (1.1)
[n = 53]
0.009
Total days of illness (from first symptoms to discharge); mean (SD) 4.6 (2.0)
[n = 38]
5.3 (4.0)
[n = 47]
0.33
Need for Readmission within 28 days; n (%) 3 (6%)
[n = 47]
0 (0%) 0.07
Dehydration; n (%) 21 (44%)
[n = 48]
16 (26%)
[n = 62]
0.07
Received IV fluids; n (%) 25 (50%) 24 (36%) 0.18
SD: Standard Deviation; IV: intravenous
n shown in square brackets where incomplete data
https://doi.org/10.1371/journal.pone.0194009.t002
Table 3. Laboratory results of children with rotavirus-positive and rotavirus-negative gastroenteritis.
Variable Rotavirus Positive Gastroenteritis
N = 50
Rotavirus Negative Gastroenteritis
N = 66
P value
pH; mean (SD) 7.30 (0.07)
[n = 21]
7.37 (0.06)
[n = 11]
0.011
Base excess, mmol/L; mean (SD) -8.5 (3.7)
[n = 21]
-3.9 (3.9)
[n = 10]
0.003
Bicarbonate, mmol/L; mean (SD) 17 (3)
[n = 21]
21 (3)
[n = 10]
0.001
Sodium, mmol/L; mean (SD) 139 (6)
[n = 42]
138 (4)
[n = 47]
0.87
Potassium, mmol/L; mean (SD) 4.4 (0.6)
[n = 39]
4.3 (0.5)
[n = 46]
0.40
Creatinine, μmol/L; mean (SD) 39 (14)
[n = 42]
34 (13)
[n = 47]
0.07
Urea, mmol/L; mean (SD) 5.9 (3.3)
[n = 41]
4.2 (1.8)
[n = 46]
0.004
Glucose, mmol/L; mean (SD) 4.6 (1.3)
[n = 23]
5.2 (1.2)
[n = 12]
0.25
ALT, IU/L; mean (SD) 40 (22)
[n = 27]
35 (53)
[n = 37]
0.007
White cell count, 109 cells/L; mean (SD) 11.4 (7.3)
[n = 34]
12.9 (6.7)
[n = 45]
0.12
Lymphocytes, 109 cells/L; mean (SD) 2.7 (2.1)
[n = 33]
4.4 (3.1)
[n = 45]
0.008
Neutrophils, 109 cells/L; mean (SD) 7.5 (6.8)
[n = 34]
6.9 (4.9)
[n = 45]
0.94
Platelets, 109 cells/L; mean (SD) 299 (117)
[n = 34]
317 (111)
[n = 45]
0.29
CRP (highest), mg/L; mean (SD) 24 (39)
[n = 36]
43 (57)
[n = 42]
0.11
Abnormal EEG; n (%) 1 (33%)
[n = 3]
0 (0%)
[n = 3]
1.00
Abnormal neuroimaging results; n (%) 1 (50%)
[n = 2]
0 (0%)
[n = 3]
0.40
SD: Standard Deviation; ALT: alanine aminotransferase; CRP: C-reactive protein; EEG: electroencephalogram
n shown in square brackets where incomplete data
https://doi.org/10.1371/journal.pone.0194009.t003
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Children with RPG compared to RNG had lower blood pH (mean(SD) 7.30(0.07) versus
7.37(0.06), P = 0.011), higher base deficit (8.5(3.7) versus 3.9(3.9) mmol/L; P = 0.003) and
lower bicarbonate (17(3) versus 21(3) mmol/L; P = 0.001). There were no significant differ-
ences in serum sodium, potassium, glucose, urea, creatinine, alanine aminotransferase, C-reac-
tive protein, neutrophils or lymphocytes between groups.
Extra-intestinal complications and co-infections
Complications among children with RPG and RNG are shown in Table 4.
Neurological complications (seizures, transient reduced consciousness, encephalopathy)
were the most common extra-intestinal manifestations of gastroenteritis, but did not differ sig-
nificantly between children with RPG and RNG (24% versus 15%, respectively; P = 0.24). Cere-
brospinal fluid culture and viral PCRs were negative in all cases where a lumbar puncture was
performed. In almost all the cases with neurological signs (21/22, 95%), gastroenteritis was
community-acquired. Three of the patients had an underlying condition, of whom one had
multiple allergies, one iron deficiency anaemia and one hypoxic ischaemic encephalopathy
(HIE). There was a trend towards more encephalopathy (3/50 (6%) versus 0/66 (0%), P = 0.08)
and reduced consciousness level (10/50 (20%) versus 5/66 (8%), P = 0.06) in children with
RPG compared to RNG, respectively. A substantial proportion of children had seizures, but
there was no statistically significant difference in prevalence between RPG and RNG groups
(10% versus 12%, respectively; P = 0.78). Other stool pathogens identified in association with
seizures were norovirus (n = 4, one of whom had co-infection with adenovirus and one with
sapovirus) and astrovirus (n = 1). No pathogens were identified in three cases. In a comparison
between patients with seizures and/or encephalopathy associated with RPG and patients with
RPG who did not have neurological signs, no significant difference was found in dehydration,
metabolic acidosis, electrolyte imbalance or hypoglycaemia (S1 Table). A higher proportion of
children with RNG compared to RPG were found to have a concomitant pathogen in the
upper respiratory tract (69% versus 27%; P = 0.03).
Discussion
In this case-control study, children with rotavirus gastroenteritis more frequently presented
with dehydration, metabolic acidosis and fever compared to children with non-rotavirus
Table 4. Complications in children with rotavirus-positive and rotavirus-negative gastroenteritis.
Variable Rotavirus Positive Gastroenteritis
N = 50
Rotavirus Negative Gastroenteritis
N = 66
P value
Acute GI complications; n (%) 1 (2%) 0 (0%) 0.43
Pathogens from the respiratory tract; n (%) 4 (27%)
[n = 15] a
11 (69%)
[n = 16] b
0.03
Pathogens from CSFc; n (%) 0 (0%)
[n = 6]
0 (0%)
[n = 5]
1.00
Neurological signs; n (%) 12 (24%) 10 (15%) 0.24
Seizures; n (%) 5 (10%) 8 (12%) 0.78
Reduced conscious level; n (%) 10 (20%) 5 (8%) 0.06
Encephalopathy; n (%) 3 (6%) 0 (0%) 0.08
GI: gastrointestinal; CSF: cerebrospinal fluid
n shown in square brackets where incomplete data
a RPG: Adenovirus (n = 1), Rhinovirus (n = 1), Parainfluenza (n = 1), Staphylococcus aureus (n = 1).
b RNG: Adenovirus (n = 4), Rhinovirus (n = 3), Metapneumovirus (n = 2), Enterovirus (n = 2), Respiratory syncytial virus (n = 1), Group G Streptococcus (n = 1).
c Viral studies performed in CSF sample included PCR for herpes simplex viruses 1+2, Varicella Zoster virus, Enterovirus, Cytomegalovirus, Epstein Barr virus. PCR for
rotavirus was performed in one sample only.
https://doi.org/10.1371/journal.pone.0194009.t004
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gastroenteritis, and were more likely to require hospitalisation. Afebrile and febrile seizures
and transient reduced consciousness were noted in a substantial proportion of children from
both groups, but encephalopathy was found only in children with rotavirus gastroenteritis.
Dehydration and metabolic acidosis secondary to fluid loss are commonly reported compli-
cations of gastroenteritis. The findings of this study are consistent with previous studies glob-
ally reporting that rotavirus causes gastroenteritis that is more severe and of longer duration
than gastroenteritis caused by other viral pathogens [11,15–18]. One of the striking findings in
the present study was the high frequency of neurological complications in previously healthy
children presenting with gastroenteritis. Seizures associated with viral gastroenteritis were first
described by Morooka in 1982 [19]. The association with rotavirus has been well documented
[20,21,22–23]. Other viruses, such as adenovirus, sapovirus and norovirus have also been
implicated [24]. The term ‘convulsions with mild gastroenteritis (CwG)’ has been widely used
to describe non-febrile seizures that are associated with gastroenteritis in the absence of clini-
cal signs of dehydration or electrolyte imbalance [25–28]. A multicentre study of 128 children
from Italy found that the onset of convulsions usually occurs within four days after the onset
of gastroenteritis. CwG are generalized in the majority of the cases (87.5%). The duration is
usually under five minutes (76%), but prolonged convulsions or status epilepticus may occur
[27]. CwG tend to present in clusters [29]. Inter-ictal EEGs are normal in the majority of
patients, but even initially abnormal EEGs tend to revert to normal during long-term follow-
up [20, 22–24, 27]. The clinical outcome of CwG is good in most children. The possibility of
developing epilepsy is low and the use of long-term treatment with antiepileptic drugs is not
recommended [22,27]. Rotavirus gastroenteritis is also associated with febrile seizures. Com-
pared to CwG, febrile seizures develop earlier during the course of the illness and tend to last
longer [30,31]. However, despite these minor differences, both febrile seizures and CwG are
considered to have a good prognosis [28,32].
Our hypothesis was that children with rotavirus gastroenteritis would have higher fre-
quency of seizures and neurological complications than children with non-rotavirus gastroen-
teritis. Although this was not confirmed, there was a trend towards more encephalopathy, with
all 3 cases occurring in the rotavirus-positive group and none in the rotavirus-negative group.
Rotavirus has been associated with various encephalopathy syndromes, such as acute necrotis-
ing encephalopathy (ANE) [32] and cerebellitis/cerebellopathy [33]. One of the patients in our
cohort was diagnosed with MERS, a transient mild encephalopathy with a reversible lesion in
the splenium of the corpus callosum on MRI [34]. In patients with MERS, delirious behaviour,
disturbance of consciousness or seizures usually present within one week after the onset of
symptoms of gastroenteritis and resolve without sequelae within ten days [35,36]. A transient
splenial lesion with reduced diffusion that appears as a high signal intensity in diffusion-
weighted MRI is the mainstay of diagnosis [37]. Rotavirus is more strongly associated with
MERS than any other syndrome of acute encephalopathy in children [38]. In a Japanese
national epidemiological survey, rotavirus was the second most common pathogen associated
with MERS after influenza virus [38].
The underlying mechamisms of neurological manifestations of rotavirus infection are not
completely understood. Detection of rotavirus RNA in CSF of some patients with CNS symp-
toms supports a hypothesis of direct viral invasion [39]. However, the significance of this find-
ing remains unclear. It has been found that viraemia occurs during the acute phase of disease
[40], but most studies in humans have failed to demonstrate a correlation between viraemia
and seizures in rotavirus gastroenteritis [41, 42]. Other mechanisms that have been proposed
to explain the association between rotavirus infection and seizures focus on the role of the
rotavirus non-structural protein 4 (NSP4) [43]. It has been suggested that NSP4 could act
either through direct CNS infection (supported by detection of rotavirus RNA in CSF), or
Complications of rotavirus gastroenteritis
PLOS ONE | https://doi.org/10.1371/journal.pone.0194009 March 22, 2018 8 / 13
indirectly by entering the bloodstream from the intestinal mucosa [43]. NSP4 has been shown
to induce nitric oxide metabolites, which are highly reactive free radicals [44]. Nitrites and
nitrates are raised in both serum and CSF in patients with rotavirus-associated seizures [45]. It
is also known that NSP4 plays a major role in mobilizing intracellular calcium. Rotavirus
causes a two- to three-fold increase in intracellular calcium concentration. Disruption of cal-
cium homeostasis induced by NSP4 plays a critical role in the pathogenesis of diarrhoea [46].
It has also been suggested that rotavirus may induce seizures, or increase susceptibility to
them, through the same NSP4-induced calcium homeostasis alterations [47]. This hypothesis
was tested in a retrospective study of 35 patients in Korea, which found lower serum calcium
levels in the patients with seizures compared to those without seizures [47]. However, it
remains to be demonstrated whether the reported decreased serum calcium concentration is
associated with alterations in neuronal calcium homeostasis.
From a clinical perspective, despite increased use of PCR testing in CSF specimens, the
number of cases of childhood encephalitis with unknown aetiology in England is increasing
[48], underlining the need for new approaches in the diagnosis of encephalitis. Failure to iden-
tify a viral cause could lead to unnecessary antimicrobial treatment. British Guidelines on
management of suspected viral encephalitis in children recommend stool PCR testing for
enteric viruses as an ancillary investigation in encephalitis associated with gastrointestinal
symptoms [49].
An association between rotavirus vaccine and decrease in seizure-related hospitalisation
and emergency department visits has been recently suggested. A retrospective analysis of
250,601 infants in the United States showed that full vaccination is associated with an 18–21%
reduction in the risk of seizures during the first year after vaccination [50]. A study from Spain
reported similar findings with a 16–34% decrease in hospitalisation rates for seizures in chil-
dren less than 5 years of age following the introduction of rotavirus immunisation [51]. The
impact of vaccination was more obvious in infants between 1 and 2 years of age with a 27–52%
decrease in hospitalisation rates for seizures. No increase of seizures in older children was
found, which might suggest a longer duration for the protective effect of vaccination [51]. It is
still unclear whether the protective effect is mainly driven by a reduction in non-febrile or
febrile seizures.
This study had strengths and limitations. We were able to select children based on molecu-
lar virology results, allowing us to compare clinical features among children with rotavirus
compared to other enteropathogens. In the hospital sites in which the study was conducted,
blood PCR for enteric viruses is not used for routine diagnostics of acute gastroenteritis, there-
fore no data on viraemia status were collected. CSF PCR for rotavirus is not part of the routine
viral panel for encephalitis and was only requested in one case. We excluded more children
than anticipated, predominantly because a fairly high proportion of those with positive PCR
results were assessed and treated outside the hospital setting. This led to a relatively small sam-
ple size, although cases and controls were well matched on age and sex. The study is limited by
its retrospective design, meaning we relied on documentation present in clinical records;
inter-observer variation in dehydration assessment and limited use of GCS to access conscious
level could have influenced our findings.
Conclusion
In summary, this study of children presenting with gastroenteritis in three UK hospitals con-
firmed that rotavirus causes more severe disease compared to other viral pathogens, with children
more likely to present with fever, dehydration and metabolic acidosis and require admission or
re-admission to hospital. Seizures and milder neurological signs were surprisingly common and
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associated with multiple pathogens, but encephalopathy occurred only in children with rotavi-
rus-positive gastroenteritis. Therefore, it is important to consider rotavirus infection in the differ-
ential diagnosis of a child with encephalopathy or encephalitis, particularly if associated with
diarrhoeal disease. Rotavirus vaccination may reduce seizures and presentation to hospital with
severe gastroenteritis, but vaccines against other pathogens causing gastroenteritis are required.
Supporting information
S1 Table. Complications in children with rotavirus-positive gastroenteritis with seizures
and/or encephalopathy and rotavirus-positive gastroenteritis without neurological symp-
toms.
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